- Home
- JAGX vs BDRX Comparison
JAGX vs BDRX Comparison
Compare JAGX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- BDRX
- Stock Information
- Founded
- JAGX 2013
- BDRX 2000
- Country
- JAGX United States
- BDRX United Kingdom
- Employees
- JAGX N/A
- BDRX N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- JAGX Health Care
- BDRX Health Care
- Exchange
- JAGX Nasdaq
- BDRX Nasdaq
- Market Cap
- JAGX 3.9M
- BDRX 4.6M
- IPO Year
- JAGX N/A
- BDRX N/A
- Fundamental
- Price
- JAGX $1.71
- BDRX $5.45
- Analyst Decision
- JAGX Strong Buy
- BDRX
- Analyst Count
- JAGX 1
- BDRX 0
- Target Price
- JAGX $60.00
- BDRX N/A
- AVG Volume (30 Days)
- JAGX 114.8K
- BDRX 487.4K
- Earning Date
- JAGX 11-14-2025
- BDRX 09-12-2025
- Dividend Yield
- JAGX N/A
- BDRX N/A
- EPS Growth
- JAGX N/A
- BDRX N/A
- EPS
- JAGX N/A
- BDRX N/A
- Revenue
- JAGX $11,810,000.00
- BDRX N/A
- Revenue This Year
- JAGX $22.41
- BDRX N/A
- Revenue Next Year
- JAGX $30.00
- BDRX N/A
- P/E Ratio
- JAGX N/A
- BDRX N/A
- Revenue Growth
- JAGX 15.96
- BDRX N/A
- 52 Week Low
- JAGX $1.57
- BDRX $5.00
- 52 Week High
- JAGX $33.25
- BDRX $92.00
- Technical
- Relative Strength Index (RSI)
- JAGX 36.00
- BDRX 38.48
- Support Level
- JAGX $1.77
- BDRX $5.00
- Resistance Level
- JAGX $2.00
- BDRX $7.84
- Average True Range (ATR)
- JAGX 0.13
- BDRX 0.66
- MACD
- JAGX -0.04
- BDRX -0.26
- Stochastic Oscillator
- JAGX 9.09
- BDRX 14.08
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.